Patents by Inventor David W. C. Hunt

David W. C. Hunt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TOFA analogs useful in treating dermatological disorders or conditions
    Patent number: 9782382
    Abstract: This invention is directed to analogs of 5-(tetradecyloxy)-2-furancarboxylic acid (TOFA) and their use in the treatment of dermatological disorders or conditions characterized by sebaceous gland hyperactivity, such as acne and oily skin, and other dermatological disorders and conditions. This invention is also directed to pharmaceutical compositions comprising analogs of TOFA and a pharmaceutically acceptable excipient for dermatological or oral administration.
    Type: Grant
    Filed: August 4, 2016
    Date of Patent: October 10, 2017
    Assignee: Dermira (Canada), Inc.
    Inventors: Timothy Scott Daynard, Geoffrey C. Winters, David W. C. Hunt
  • TOFA ANALOGS USEFUL IN TREATING DERMATOLOGICAL DISORDERS OR CONDITIONS
    Publication number: 20160338988
    Abstract: This invention is directed to analogs of 5-(tetradecyloxy)-2-furancarboxylic acid (TOFA) and their use in the treatment of dermatological disorders or conditions characterized by sebaceous gland hyperactivity, such as acne and oily skin, and other dermatological disorders and conditions. This invention is also directed to pharmaceutical compositions comprising analogs of TOFA and a pharmaceutically acceptable excipient for dermatological or oral administration.
    Type: Application
    Filed: August 4, 2016
    Publication date: November 24, 2016
    Inventors: Timothy Scott Daynard, Geoffrey C. Winters, David W.C. Hunt
  • TOFA analogs useful in treating dermatological disorders or conditions
    Patent number: 9434718
    Abstract: This invention is directed to analogs of 5-(tetradecyloxy)-2-furancarboxylic acid (TOFA) and their use in the treatment of dermatological disorders or conditions characterized by sebaceous gland hyperactivity, such as acne and oily skin, and other dermatological disorders and conditions. This invention is also directed to pharmaceutical compositions comprising analogs of TOFA and a pharmaceutically acceptable excipient for dermatological or oral administration.
    Type: Grant
    Filed: October 3, 2014
    Date of Patent: September 6, 2016
    Assignee: DERMIRA (CANADA), INC.
    Inventors: Timothy Scott Daynard, Geoffrey C. Winters, David W. C. Hunt
  • TOFA ANALOGS USEFUL IN TREATING DERMATOLOGICAL DISORDERS OR CONDITIONS
    Publication number: 20150025069
    Abstract: This invention is directed to analogs of 5-(tetradecyloxy)-2-furancarboxylic acid (TOFA) and their use in the treatment of dermatological disorders or conditions characterized by sebaceous gland hyperactivity, such as acne and oily skin, and other dermatological disorders and conditions. This invention is also directed to pharmaceutical compositions comprising analogs of TOFA and a pharmaceutically acceptable excipient for dermatological or oral administration.
    Type: Application
    Filed: October 3, 2014
    Publication date: January 22, 2015
    Inventors: Timothy Scott Daynard, Geoffrey C. Winters, David W.C. Hunt
  • TOFA analogs useful in treating dermatological disorders or conditions
    Patent number: 8884034
    Abstract: This invention is directed to analogs of 5-(tetradecyloxy)-2-furancarboxylic acid (TOFA) and their use in the treatment of dermatological disorders or conditions characterized by sebaceous gland hyperactivity, such as acne and oily skin, and other dermatological disorders and conditions. This invention is also directed to pharmaceutical compositions comprising analogs of TOFA and a pharmaceutically acceptable excipient for dermatological or oral administration.
    Type: Grant
    Filed: July 1, 2010
    Date of Patent: November 11, 2014
    Assignee: Dermira (Canada), Inc.
    Inventors: Timothy Scott Daynard, Geoffrey C. Winters, David W. C. Hunt
  • Pharmaceutical Compositions for Topical Delivery of Photosensitizers and Uses Thereof
    Publication number: 20130289089
    Abstract: The invention includes and provides compositions comprising photosensitizing agents, in particular lemuteporfin, and their use in photo-dynamic therapy for the treatment of dermatological conditions.
    Type: Application
    Filed: January 13, 2012
    Publication date: October 31, 2013
    Inventors: Jerome A. Morris, Deepank Utkhede, David W.C. Hunt
  • TOFA ANALOGS USEFUL IN TREATING DERMATOLOGICAL DISORDERS OR CONDITIONS
    Publication number: 20120208807
    Abstract: This invention is directed to analogs of 5-(tetradecyloxy)-2-furancarboxylic acid (TOFA) and their use in the treatment of dermatological disorders or conditions characterized by sebaceous gland hyperactivity, such as acne and oily skin, and other dermatological disorders and conditions. This invention is also directed to pharmaceutical compositions comprising analogs of TOFA and a pharmaceutically acceptable excipient for dermatological or oral administration.
    Type: Application
    Filed: July 1, 2010
    Publication date: August 16, 2012
    Applicant: VALOCOR THERAPEUTICS, INC.
    Inventors: Timothy Scott Daynard, Geoffrey C. Winters, David W.C. Hunt
  • Treatment of inflammatory diseases including psoriasis
    Patent number: 7863429
    Abstract: Inhibitors of integrin-linked kinase (ILK) are used in the treatment of inflammatory disease, including cutaneous inflammatory diseases, such as psoriasis, scleroderma, systemic lupus erythematosus and atopic dermatitis.
    Type: Grant
    Filed: November 30, 2001
    Date of Patent: January 4, 2011
    Assignees: QLT Inc., Sunnybrook and Women's College and Health Science Centre
    Inventors: Shoukat Dedhar, Greg Hannigan, David W. C. Hunt, Jing-Song Tao, Ladan Fazli
  • Immuno-adjuvant PDT treatment of metastatic tumors
    Patent number: 7850981
    Abstract: Immuno-adjuvant photodynamic therapy to treat and prevent metastatic cancer is effected using photosensitizers in combination with immuno-adjuvants to destroy metastatic tumor cells.
    Type: Grant
    Filed: November 9, 2004
    Date of Patent: December 14, 2010
    Assignees: QLT, Inc., University of British Columbia (UBC)
    Inventors: Patrick Mark Curry, Anna M. Richter, Julia G. Levy, David W. C. Hunt
  • METHODS OF TREATING DERMATOLOGICAL DISORDERS OR CONDITIONS
    Publication number: 20100204317
    Abstract: This invention is directed to the use of TOFA in the treatment of acne and other dermatological disorders. This invention is also directed to pharmaceutical compositions comprising TOFA and a pharmaceutically acceptable excipient for dermatological or oral administration.
    Type: Application
    Filed: November 2, 2007
    Publication date: August 12, 2010
    Applicant: QLT INC.
    Inventors: David W.C. Hunt, Jerome Arthur Morris, Huijun Jiang, Danny Leung, Ronald Erwin Boch
  • Photodynamic therapy for the treatment of acne
    Publication number: 20100056982
    Abstract: The present method involves the photodynamic treatment of acne vulgaris. The method involves the topical administration of a photosensitizer composition comprising hydrophobic green porphyrins such as lemuteporfin, polyethylene glycol and skin penetration enhancers such as oleyl alcohol and TRANSCUTOL™ to acne-affected skin and subsequent exposure of that skin to energy of a wavelength of activating the photosensitizer.
    Type: Application
    Filed: February 4, 2005
    Publication date: March 4, 2010
    Applicant: QLT Inc.
    Inventors: Alain H. Curaudeau, Herma C. Neyndorff, Jinj-Song Tao, Morgan Chun Lam, Patrick Mark Curry, Valery Rubinchik, David W.C. Hunt
  • ETHYLENE GLYCOL ESTERS AS PHOTOACTIVE AGENTS
    Publication number: 20090203757
    Abstract: New compounds useful in photodynamic therapy are of the formula and their 1,4-diene isomers and the metallated and/or labeled and/or conjugated forms thereof wherein each R1 is independently alkyl (1-6C); each n is independently an integer of 0-6; and R2 is vinyl or a derivative form thereof.
    Type: Application
    Filed: April 23, 2009
    Publication date: August 13, 2009
    Inventors: Ethan D. STERNBERG, David DOLPHIN, Julia G. LEVY, Anna M. RICHTER, David W.C. HUNT, Ashok JAIN, Elizabeth M. WATERFIELD, Ronald E. BOCH, Andrew Norman TOVEY
  • Photodynamic Therapy For The Treatment Of Hyperactive Sebaceous Gland Disorders Using Topically Applied Hydrophobic Green Porphyrins
    Publication number: 20080096857
    Abstract: The present method involves the photodynamic treatment of hyperactive gland disorders. The method involves the topical administration of a photosensitizer composition comprising hydrophobic and/or lipophilic green porphyrins such as lemuteporfin, polyethylene glycol and skin penetration enhancers such as oleyl alcohol and TRANSCUTOL™ to affected skin and subsequent exposure of that skin to energy of a wavelength capable of activating the photosensitizer.
    Type: Application
    Filed: February 8, 2005
    Publication date: April 24, 2008
    Applicant: QLT Inc.
    Inventors: Alain H. Curaudeau, Herma C. Neyndorff, Jing-Song Tao, Julia G. Levy, David W.C. Hunt, Morgan Chun Lam, Patrick Mark Curry, Valery Rubinchik
  • Photodynamic therapy for the treatment of hair loss
    Patent number: 7264629
    Abstract: Photodynamic therapy (PDT) is used to stimulate and/or restore hair growth in areas of hair loss. Methods and compositions relating to PDT treatment for alopecia are disclosed. In light of PDT use to remove unwanted hair by inactivating or destroying hair follicles or destroying the tissue feeding the hair follicles, such methods and compositions relate to a surprising and unexpected discovery. PDT permits a means to treat conditions relating to hair loss such as androgenic alopecia, alopecia areata and drug-induced alopecia.
    Type: Grant
    Filed: April 23, 2003
    Date of Patent: September 4, 2007
    Assignee: QLT, Inc.
    Inventors: Guillermo O. Simkin, Anna M. Richter, David W. C. Hunt, John Robert North, Peter Lutwyche, Ronald Erwin Boch, Jean-Marie Houle
  • Ethylene glycol esters as photoactive agents
    Patent number: 7122569
    Abstract: New compounds useful in photodynamic therapy are of the formula and their 1,4-diene isomers and the metallated and/or labeled and/or conjugated forms thereof wherein each R1 is independently alkyl (1–6C); each n is independently an integer of 0–6; and R2 is vinyl or a derivative form thereof.
    Type: Grant
    Filed: April 14, 2004
    Date of Patent: October 17, 2006
    Assignees: QLT, Inc. and, University of British Columbia
    Inventors: Ethan D. Sternberg, David Dolphin, Julia G. Levy, Anna M. Richter, David W. C. Hunt, Ashok Jain, Elizabeth M. Waterfield, Ronald E. Boch, Andrew Norman Tovey
  • Photodynamic therapy for the treatment of hair loss
    Patent number: 7090691
    Abstract: Photodynamic therapy (PDT) is used to stimulate and/or restore hair growth in areas of hair loss. Methods and compositions relating to PDT treatment for alopecia are disclosed. In light of PDT use to remove unwanted hair by inactivating or destroying hair follicles or destroying the tissue feeding the hair follicles, such methods and compositions relate to a surprising and unexpected discovery. PDT permits a means to treat conditions relating to hair loss such as androgenic alopecia, alopecia areata and drug-induced alopecia.
    Type: Grant
    Filed: November 8, 2002
    Date of Patent: August 15, 2006
    Assignee: QLT Inc.
    Inventors: Guillermo O. Simkin, Anna M. Richter, David W. C. Hunt, John Robert North, Peter Lutwyche, Ronald Erwin Boch
  • Ethylene glycol esters as photoactive agents
    Patent number: 6756396
    Abstract: New compounds useful in photodynamic therapy are of the formula and their 1,4-diene isomers and the metallated and/or labeled and/or conjugated forms thereof wherein each R1 is independently alkyl (1-6C); each n is independently an integer of 0-6; and R2 is vinyl or a derivative form thereof.
    Type: Grant
    Filed: June 6, 2000
    Date of Patent: June 29, 2004
    Assignees: QLT Inc., The University of British Columbia
    Inventors: Ethan Sternberg, David Dolphin, Julia G. Levy, Anna M. Richter, David W. C. Hunt, Ashok Jain, Elizabeth M. Waterfield, Ronald E. Boch
  • Photodynamic therapy for the treatment of hair loss
    Publication number: 20040029856
    Abstract: Photodynamic therapy (PDT) is used to stimulate and/or restore hair growth in areas of hair loss. Methods and compositions relating to PDT treatment for alopecia are disclosed. In light of PDT use to remove unwanted hair by inactivating or destroying hair follicles or destroying the tissue feeding the hair follicles, such methods and compositions relate to a surprising and unexpected discovery. PDT permits a means to treat conditions relating to hair loss such as androgenic alopecia, alopecia areata and drug-induced alopecia.
    Type: Application
    Filed: April 23, 2003
    Publication date: February 12, 2004
    Inventors: Guillermo O. Simkin, Anna M. Richter, David W. C. Hunt, John Robert North, Peter Lutwyche, Ronald Erwin Boch, Jean-Marie Houle
  • Photodynamic therapy for the treatment of hair loss
    Publication number: 20040015214
    Abstract: Photodynamic therapy (PDT) is used to stimulate and/or restore hair growth in areas of hair loss. Methods and compositions relating to PDT treatment for alopecia are disclosed. In light of PDT use to remove unwanted hair by inactivating or destroying hair follicles or destroying the tissue feeding the hair follicles, such methods and compositions relate to a surprising and unexpected discovery. PDT permits a means to treat conditions relating to hair loss such as androgenic alopecia, alopecia areata and drug-induced alopecia.
    Type: Application
    Filed: November 8, 2002
    Publication date: January 22, 2004
    Inventors: Guillermo O. Simkin, Anna M. Richter, David W. C. Hunt, John Robert North, Peter Lutwyche, Ronald Erwin Boch
  • Photodynamic therapy (PDT) in combination with factors that bind cell surface apoptosis-inducing receptors
    Publication number: 20030008857
    Abstract: The invention relates to photodynamic therapy (PDT) is used in combination with apoptosis-inducing agents to destroy target cells and tissues. Benefits of such combinations include 1) the ability to use lower doses of photosensitizers and/or light; 2) the ability to use lower doses of apoptosis-inducing agents; and 3) the ability to use apoptosis-inducing agents against target tissues which are otherwise insensitive to the apoptosis-inducing agents.
    Type: Application
    Filed: July 10, 2002
    Publication date: January 9, 2003
    Inventors: David W.C. Hunt, Christopher M. Carthy, David Granville